Abstract: The invention relates to the field of treating Parkinson’s disease. More particularly, it relates to the use of anethole trithione on its own or in combination with an anti-synuclein tetracycline in the treatment of Parkinson’s disease.

Abstract: A method of treating a subject for reducing the risk of QT space prolongation associated with the intake of a drug known to prolong QT space includes administering to the subject at least one specific inhibitor of mitochondrial ROS production selected from among anethole trithione (ATT), 4-OH-anethole trithione (ATX), and an ATX ester, and administering to the subject the drug known to prolong QT space.

Abstract: The present invention relates to desmethylanethole trithione (AOX) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin,

Abstract: A method of preventing and/or treating disease in which reactive oxygen species (or ROSs) of mitochondrial origin are involved. The method involves use of an inhibitor of mitochondrial ROS production, in particular, of anethole trithione, for the prevention and/or treatment of benign prostatic hyperplasia.

Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.

Abstract: The present invention relates to desmethylanethole trithione (AOX) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin,

Abstract: A method of treating a subject for reducing the risk of QT space prolongation associated with the intake of a drug known to prolong QT space includes administering to the subject at least one specific inhibitor of mitochondrial ROS production selected from among anethole trithione (ATT), 4-OH-anethole trithione (ATX), and an ATX ester, and administering to the subject the drug known to prolong QT space.

Abstract: A method of preventing and/or treating disease in which reactive oxygen species (or ROSs) of mitochondrial origin are involved. The method involves use of an inhibitor of mitochondrial ROS production, in particular, of anethole trithione, for the prevention and/or treatment of benign prostatic hyperplasia.

Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.

Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.

Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.

Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.

Abstract: The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.

Abstract: The invention relates to a heat treatment oven comprising a loading or treatment zone, at least one gas inlet, a gas preheater chamber situated in the oven between the gas inlet and the loading or treatment zone, a susceptor comprising at least a side wall surrounding the preheater chamber and the loading or treatment zone, and a field winding suitable for heating the side wall by induction. The portion of the side wall of the susceptor that is situated around the preheater chamber presents at least two recesses spaced apart circumferentially from one another so as to form portions of reduced thickness in said portion of the side wall.

Abstract: The invention relates to a heat treatment oven comprising a loading or treatment zone, at least one gas inlet, a gas preheater chamber situated in the oven between the gas inlet and the loading or treatment zone, a susceptor comprising at least a side wall surrounding the preheater chamber and the loading or treatment zone, and a field winding suitable for heating the side wall by induction. The portion of the side wall of the susceptor that is situated around the preheater chamber presents at least two recesses spaced apart circumferentially from one another so as to form portions of reduced thickness in said portion of the side wall.

Abstract: The present invention relates to a method of treatment of bacterial infections including administering an effective amount of an oral time-dependent antibiotic to a human or warm blooded animal.

Abstract: A pipe for feeding a gas into an oven, a furnaces, or the like (such as a CVI/CVD oven), and in particular into a reaction chamber structure inside the oven, is provided with a gastight tubular sealing device extending radially outward of the pipe and defining a path that is practically gastight, through which there extends the feed pipe. The tubular sealing device is preferably at least partially flexible in the transverse direction and/or the axial direction so as to accommodate positioning defects between a location situated in the reaction chamber and a location where the gas feed pipe penetrates the oven (which defects may be due, for example, to asymmetrical thermal expansion/contraction).

Abstract: A pipe for feeding a gas into an oven, a furnaces, or the like (such as a CVI/CVD oven), and in particular into a reaction chamber structure inside the oven, is provided with a gastight tubular sealing device extending radially outside the pipe and defining a path that is practically gastight, along which there extends the as feed pipe. The tubular sealing device is preferably at least partially flexible in the transverse direction and/or the axial direction so as to accommodate positioning defects between a location situated in the reaction chamber and a location where the gas feed pipe penetrates into the oven (which defects may be due, for example, to asymmetrical thermal expansion/contraction).